Cipla Q4 Results: Pharmaceuticals company Cipla on Tuesday, May 13, reported a 30.12 per cent year-on-year (YoY) rise in its Q4FY25 consolidated net profit to ₹1,221.84 crore compared to ₹939.04 crore in the corresponding quarter of the previous financial year.
Revenue from sales rose 8.5 per cent YoY to ₹6,597.72 crore from ₹6,082.37 crore in Q4FY24.
(This is a developing story. Please check back for fresh updates.)
